APP and Alzheimer disease: To determine whether the expression of DDX17 is associated with AD, we first examined the protein levels of DDX17 in HEK-APP and SH-SY5Y-APP (Y5Y-APP) cells, which could serve as a cellular model of AD because of the higher Aβ levels as a result of APP overexpression [38].